Search
Desonide Topical (DesOwen, Tridesilon)
Non-fluorinated topical glucocorticoid.
Indications:
- adjunctive therapy for inflammation & pruritus in acute & chronic, glucocorticoid-responsive dermatoses
- seborrheic dermatitis [2]
- allergic dermatitis, atopic dermatitis, contact dermatitis
- discoid lupus
- granuloma annulare
- psoriasis
- lichen simplex chronicus [2]
- cutaneous T-cell lymphoma [2]
Contraindications:
- do not use on eyelid
Dosage: Topical: apply BID-QID
Cream: 0.05% (15g, 30 g, 60g)
Ointment: 0.05% (15g, 60g)
Adverse effects:
- uncommon (< 1%)
- burning, itching, irritation, dryness, folliculitis, hypertrichosis, acne, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin maceration, secondary infection, skin atrophy, striae, miliaria
Mechanism of action:
- anti-inflammatory; topical glucocorticoid class 5 [3]
Interactions
drug adverse effects of glucocorticoids
monitor with drug (more general terms)
General
desonide; prednacinolone
topical glucocorticoid (topical steroid)
Database Correlations
PUBCHEM correlations
References
- Kaiser Permanente Northern California Regional Drug
Formulary, 1998
- Deprecated Reference
- Medical Knowledge Self Assessment Program (MKSAP) 17,
American College of Physicians, Philadelphia 2015